Industries > Pharma > Global Immunochemistry Reagents, Analyzers and Test Kits Market 2019-2029

Global Immunochemistry Reagents, Analyzers and Test Kits Market 2019-2029

Reagents and Test Kits, Analyzers, Disease Specific Tests, Rapid Tests, Drugs of Abuse/Toxicology Tests, Endocrinology Tests, Therapeutic Drug Monitoring Tests, Anemia/Vitamin Tests, Allergic Blood Tests, Autoimmune Diseases, Cardiac Markers, Infectious Diseases, Tumor Markers, Chemiluminescence Analyzers, ELISA Analyzers, Immunofluorescence Analyzers, Radioimmunoassay Analyzers

PUBLISHED: 30 September 2019
PAGES: 184
PRODUCT CODE: PHA0525
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
SKU: PHA0525 Categories: , Tags: , , , , , ,

The global immunochemistry reagents, analyzers and test kits market is estimated to have reached $23bn in 2018 and is expected to grow at a CAGR of 8.5% in the first half of the forecast period. The Disease Specific Test submarket held 42% of the global immunochemistry reagents, analyzers and test kits market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 184-page report you will receive 57 tables and 75 figures– all unavailable elsewhere.

The 184-page report provides clear detailed insight into immunochemistry reagents, analyzers and test kits market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Immunochemistry Reagents, Analyzers and Test Kits Market forecasts from 2019-2029

• Along with revenue prediction for the overall world market, you see forecasts to 2029 for these submarkets:
• Immunochemistry reagents and tests kits
• Immunochemistry analysers

• The study also forecasts immunochemistry reagents and tests kits subsectors:
• Anaemia/Vitamin tests
• Disease specific tests
• Drugs of abuse/toxicology tests
• Therapeutic drug monitoring
• Endocrinology tests
• Rapid tests

Global Immunochemistry Reagents, Analyzers and Test Kits Market 2019-2029

• Our report provides revenues to 2029 for the sub-segments of the immunochemistry analysers, which includes:
• Chemiluminescence analysers
• ELISA analysers
• Immunofluorescence analysers
• Radioimmunoassay analysers

• This report forecasts the size of the immunochemistry market in these regional and national market:
• North America: US & Canada
• Europe: Germany, France, Italy, Spain, UK, Rest of Europe
• Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
• Latin America: Brazil, Mexico, Rest of Latin America
• Middle East and Africa: South Africa, GCC Countries, Rest of MEA

Each regional market forecast is further segmented into Immunochemistry Reagents and Test Kits Market and Immunochemistry Analyzers Market.

• Profiles and generic drugs revenue forecasts from 2019-2029 of these selected leading companies:
• Abbott
• bioMerieux
• Danaher
• Fujirebio
• Ortho Clinical Diagnostics
• Roche
• Siemens
• Sysmex Corporation
• Thermo Fisher Scientific
• Trivitron Healthcare Pvt. Ltd.

• Qualitative analysis of the generic drugs market:
SWOT Analysis of the Global Immunochemistry Reagents, Analyzers and Test Kits Market
• Discussion on factors that drive and restrain the Global Immunochemistry Reagents, Analyzers and Test Kits Market

• Key Questions Answered by This Report:
• How is the immunochemistry market evolving?
• What is driving and restraining the immunochemistry industry?
• What are the market shares of the main segments of the immunochemistry field in 2018?
• How will each immunochemistry submarket grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for immunochemistry submarkets develop from 2019-2029?
• What will be the main sales drivers for the overall market from 2019-2029?
• How will the market shares of the top regional markets change by 2029, and which will lead the market then?
• Who are the leading companies, and what are their prospects from 2018?
• What are the trends for M&A activity, consolidation for existing players and the potential for new market entrants?
• How will that industry evolve between 2018 and 2029? Where does it head?

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Immunochemistry Reagents, Analyzers and Test Kits Market. You find data, trends and predictions.

Buy our report today Global Immunochemistry Reagents, Analyzers and Test Kits Market 2019-2029: Reagents and Test Kits, Analyzers, Disease Specific Tests, Rapid Tests, Drugs of Abuse/Toxicology Tests, Endocrinology Tests, Therapeutic Drug Monitoring Tests, Anemia/Vitamin Tests, Allergic Blood Tests, Autoimmune Diseases, Cardiac Markers, Infectious Diseases, Tumor Markers, Chemiluminescence Analyzers, ELISA Analyzers, Immunofluorescence Analyzers, Radioimmunoassay Analyzers.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Immunochemistry Reagents, Analyzers and Test Kits Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Immunochemistry Reagents, Analyzers and Test Kits Market 2019-2029


Latest Pharma news

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

READ

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

READ

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Categories

Category